A share price of Catalyst Pharmaceuticals Inc [CPRX] is currently trading at $21.73, up 2.89%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CPRX shares have gain 4.47% over the last week, with a monthly amount glided 1.26%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Catalyst Pharmaceuticals Inc [NASDAQ: CPRX] stock has seen the most recent analyst activity on February 04, 2025, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $28. Previously, Stephens started tracking the stock with Overweight rating on November 18, 2024, and set its price target to $35. On March 14, 2024, Citigroup initiated with a Buy rating and assigned a price target of $27 on the stock. BofA Securities started tracking the stock assigning a Buy rating and suggested a price target of $23 on March 07, 2024. Oppenheimer initiated its recommendation with a Outperform and recommended $30 as its price target on December 21, 2023. ROTH Capital downgraded its rating to Neutral for this stock on August 24, 2022, and upped its price target to $15.50. In a note dated September 21, 2018, Cantor Fitzgerald initiated an Overweight rating.
Catalyst Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $15.34 and $26.58. Currently, Wall Street analysts expect the stock to reach $32 within the next 12 months. Catalyst Pharmaceuticals Inc [NASDAQ: CPRX] shares were valued at $21.73 at the most recent close of the market. An investor can expect a potential return of 47.26% based on the average CPRX price forecast.
Analyzing the CPRX fundamentals
Trailing Twelve Months sales for Catalyst Pharmaceuticals Inc [NASDAQ:CPRX] were 534.65M which represents 43.56% growth. Gross Profit Margin for this corporation currently stands at 0.83% with Operating Profit Margin at 0.43%, Pretax Profit Margin comes in at 0.48%, and Net Profit Margin reading is 0.37%. To continue investigating profitability, this company’s Return on Assets is posted at 0.22, Equity is 0.28 and Total Capital is 0.29. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Catalyst Pharmaceuticals Inc [NASDAQ:CPRX] is 6.14. In addition, the Quick Ratio stands at 5.96 and the Cash Ratio stands at 5.2. Considering the valuation of this stock, the price to sales ratio is 4.96, the price to book ratio is 3.34 and price to earnings (TTM) ratio is 13.87.
Transactions by insiders
Recent insider trading involved Sundaram Preethi, Chief Strategy Officer, that happened on Jun 10 ’25 when 2324.0 shares were sold. Chief Strategy Officer, Sundaram Preethi completed a deal on Jun 11 ’25 to sell 1600.0 shares. Meanwhile, Officer Sundaram Preethi bought 1600.0 shares on Jun 11 ’25.
